Clinical Trial Update: A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety, and tolerability of AMG 416 in secondary hyperparathyroidism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• AMG 416

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism | Phase 1 | Status: COMPLETED | Results posted: 2020-02-10